TMCi: Accelerator for Cancer Therapeutics Program

• Emily Reiser, PhD (Moderator) Texas Medical Center
• Dan Hargrove, JD, LLM CPRIT Product Development Advisory Committee Member
• Suzanne Tomlinson, PhD, MBA Gulf Coast Consortia for Quantitative Biomedical Sciences
• Cassian Yee, MD The University of Texas MD Anderson Cancer Center

October 2, 2023
from 1:15 PM - 2:05 PM

Expo Hall A 4

The TMCi ACT program is funded by CPRIT and was launched in collaboration with the Gulf Coast Consortia (GCC). The program supports Texas-based entrepreneurs and researchers developing cancer therapeutics. Leaders of the program, mentors, and entrepreneurs will discuss translating science in the ACT accelerator program.